| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |